News
Things are moving quickly at Blueprint Medicines. | As it looks to fulfill the potential of newly approved Ayvakit, Blueprint Medicines has promoted two people to its C-Suite. Philina Lee, Ph.D ...
The C-Suite Imperative: Lead From The Front Transforming into an AI-first organization is not an IT-led project—it’s a business transformation led by the C-suite.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback